AVTR vs GSK · P/E 13, rev $6.55B vs P/E 13, $103.31B cap
Avantor Inc (AVTR) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Avantor Inc (AVTR) is a medical instruments & supplies company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported AVTR revenue for 2025-12-31 was $6.55B. Net income was -$530.2M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. AVTR currently screens at market cap $9.36B and trailing P/E 13.3.
GSK does not have a complete income-statement cache yet.
AVTR currently screens at market cap $9.36B and trailing P/E 13.3. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the AVTR and GSK stock pages for the full models.
Not investment advice.